Name: 글로벌 시장 동향
SKU: HCIT7771
Availability: InStock

보고서 요약(국문)

개요
글로벌 의료 데이터 상호운용성 시장은 2022년 XX억 달러 규모에 도달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 기록하며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
의료 데이터 상호운용성은 개인 및 인구 집단의 건강 결과를 최적화하기 위해 전자 건강 데이터에 대한 시의적절하고 안전한 접근, 통합 및 활용을 의미합니다. 상호운용성은 공통 언어를 사용하여 여러 의료 시설에서 환자 파일에 더 빠르고 효율적으로 접근할 수 있도록 시스템 통신을 현대화합니다.
상호운용성은 조직이 개인 의료 정보의 사용 및 공유 방식을 완전히 평가하도록 요구함으로써 환자 데이터의 개인 정보 보호 및 보안을 강화하는 데 도움이 될 수 있습니다. 주요 역할은 전송 및 수신되는 데이터가 사용 가능하고 즉시 공유될 수 있도록 보장하는 것입니다.
시장 동향
디지털 의료 솔루션의 도입 증가
디지털 의료 솔루션의 도입 증가는 시장 성장의 중요한 동인입니다. 전 세계적으로 인구 고령화와 수명 연장이 진행됨에 따라 효과적인 의료 서비스를 제공하기 위해 상호운용성과 데이터 공유는 더욱 중요해질 것입니다. 상호운용성은 조직이 데이터 추세와 과거 성과를 분석하고 환자 치료 및 기타 영역에서 데이터 기반 개선을 이룰 수 있도록 지원합니다.
예를 들어, 2023년 3월 EHR 공급업체인 NextGen Healthcare는 의료 상호운용성을 간소화하는 것을 목표로 하는 클라우드 기반 솔루션인 Mirth Cloud Connect를 출시했습니다. 이 도구는 여러 신뢰할 수 있는 소스에서 환자 데이터 흐름을 통합하여 진료 현장에서 실행 가능한 통찰력을 제공합니다.
또한 2023년 4월 Particle Health는 단일 API를 사용하여 소프트웨어 기반 의료 기관에 상호운용성을 제공하는 Particle for Platforms라는 새로운 기능을 출시했습니다. 이 서비스는 다른 유용한 데이터 소스에 대한 액세스와 함께 CommonWell Health Alliance, Carequality 및 eHealth Exchange에 연결되는 상호운용성 게이트웨이를 제공합니다.
더 나아가 의료 시설 개선을 위한 투자 증가와 환자 치료 개선을 위한 정부 정책과 같은 주요 성장 동력이 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다.

상호운용성 솔루션 관련 과제
EHR 기술의 발전과 도입에도 불구하고, 이러한 시스템은 여전히 데이터 사일로를 야기하여 상호운용성에 상당한 어려움을 초래합니다. 예를 들어, 국가 환자 식별자(NPID)의 부재는 진정한 EHR 상호운용성(NPID)을 가로막는 가장 중요한 장벽 중 하나입니다. EHR이 환자 및 건강 데이터의 주요 저장소이자 접근 수단인 경우, 의료기관 간 또는 의료기관 내에서 환자를 식별하고 환자 기록을 일치시키는 데 어려움이 발생합니다.
세그먼트 분석
글로벌 의료 데이터 상호운용성 시장은 수준, 유형, 최종 사용자 및 지역별로 세분화됩니다.
EHR 상호운용성 부문은 시장 점유율의 약 48.5%를 차지했습니다.
EHR 상호운용성 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 상호운용 가능한 전자 건강 기록(EHR)은 서로 다른 EHR 시스템과 의료기관 간에 환자 정보를 전자적으로 공유할 수 있도록 하여 의사가 환자를 진료하고 여러 의료기관을 오가는 것을 더욱 용이하게 합니다. EHR은 정보 차단을 초래하지 않는 가장 간단하고 안전한 옵션 중 하나로 널리 인정받고 있습니다.
예를 들어, 2021년 5월 Automation Anywhere, Inc.는 미국 최대 EHR 공급업체 중 하나인 Epic Systems의 전자 건강 기록(EHR) 접근을 자동화하는 새로운 클라우드 기반 Epic Fast Healthcare Interoperability Resources(FHIR) API Bot을 출시했습니다.
또한, 2023년 4월 Intermountain Health의 의료 정보 전문가들은 근거 기반 의학과 인공지능을 활용하여 환자 치료를 가속화하고 전자 건강 기록과 실시간으로 통합하는 임상 의사 결정 지원 플랫폼을 개발했습니다. 따라서 위와 같은 요인들로 인해 해당 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
지역 분석
북미는 글로벌 의료 데이터 상호 운용성 시장에서 상당한 비중을 차지할 것으로 예상됩니다.
북미는 디지털 의료 서비스에 대한 수요 증가, 신제품 출시, 의료비 지출 증가 등의 요인으로 인해 상당한 시장 점유율을 유지해 왔으며, 이러한 추세는 예측 기간 동안 지속될 것으로 예상됩니다.

예를 들어, 2023년 2월, 의료 데이터 상호운용성 분야의 선두 기업인 Redox와 Google Cloud는 의료 기관이 더 나은 결정을 더 빠르게 내릴 수 있도록 의료 데이터 교환을 간소화하기 위한 파트너십을 체결했습니다.
또한, 2023년 7월 GroundGame.Health(GGH)는 USAing과 협력하여 2023년 컨퍼런스 및 전시회에서 새로운 상호운용성 및 데이터 친화성 그룹을 출범시켰습니다.
COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 의료 데이터 상호운용성 시장에 상당한 긍정적 영향을 미쳤습니다. 개별 환자의 전체 의료 여정을 파악하는 것부터 지역 사회 수준에서 집계된 데이터를 분석하는 것까지, 최전선 의료진과 연구자들은 질병을 추적하고, 가장 효과적인 프로토콜을 결정하고, 바이러스 확산을 막기 위해 가장 포괄적인 데이터 세트에 접근해야 합니다.
상호운용성은 인구 수준에서 백신 효능을 측정하는 데 많은 이점을 제공합니다. 과학자들은 거시적 수준에서 데이터를 공유할 수 있을 때 다양한 인구 집단에 대한 백신의 영향과 의료 서비스 접근성이 낮은 인구 집단에서 백신 배포 불균형이 미치는 영향을 연구할 수 있습니다.

시장 세분화
수준별
• 기초 수준
• 구조적 수준
• 의미론적 수준
• 조직적 수준
• 유형별
• 솔루션
o EHR 상호운용성
o HIE 상호운용성
o 기타
• 서비스
최종 사용자별
• 의료 서비스 제공자
• 의료 보험사
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 기업으로는 Koninklijke Philips N.V., Epic Systems Corporation, Veradigm LLC, Cerner Corporation, Orion Health, OSP Labs, CES Limited, NextGen Healthcare Inc., ViSolve Inc., 및 InterSystems 등이 있습니다. 주요 기업을 포함한 여러 기업.
주요 개발 사항
• 2023년 10월, 필립스는 병원 최초로 필립스 캡슐 의료기기 정보 플랫폼(MDIP)과 필립스 환자 정보 센터 iX의 상호 운용성을 도입했습니다.
보고서 구매 이유

• 유형, 캡슐 크기, 최종 사용자 및 지역별 글로벌 의료 데이터 상호 운용성 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위해.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별하기 위해.

• 모든 세그먼트를 포함한 의료 데이터 상호 운용성 시장 수준의 다양한 데이터 포인트가 담긴 엑셀 데이터 시트 제공.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서 제공.

• 주요 기업의 핵심 제품을 모두 포함하는 제품 매핑 엑셀 파일 제공.

글로벌 의료 데이터 상호 운용성 시장 보고서는 약 61개의 표, 63개의 그림, 185페이지 분량으로 구성됩니다.

2023년 목표 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Healthcare Data Interoperability Market reached US$ XX billion in 2022 and is expected to reach US$ XX million by 2030 growing at a CAGR of XX% during the forecast period 2023-2030.
Healthcare Interoperability refers to timely and secure access, integration, and use of electronic health data so that it can be used to optimize health outcomes for individuals and populations. Interoperability modernizes systems communications for better and quicker access to patient files across multiple healthcare facilities by using a common language.
Interoperability can help enhance patient data privacy and security by requiring organizations to fully assess how their private health information is being used and shared. The major role is to ensure that the data that is being transmitted and received are usable and immediately available to share.
Market Dynamics
The increasing adoption of digital healthcare solutions
The increasing adoption of digital healthcare solutions acts as a significant driver for market growth. Interoperability and data sharing will become increasingly important for delivering effective healthcare as populations worldwide age and people live longer lives. Interoperability enables organizations to examine data trends and past performance and make data-driven improvements in patient care and other areas.
For instance, in March 2023, EHR vendor NextGen Healthcare launched the Mirth Cloud Connect, a cloud-based solution that aims to streamline healthcare interoperability. The tool integrates patient data flow from multiple trusted sources for actionable insights at the point of care.
Additionally, in April 2023, Particle Health released a new feature called Particle for Platforms, which uses a single API to provide software-enabled healthcare organizations with interoperability. Along with access to other useful data sources, the service offers an interoperability gateway that connects to CommonWell Health Alliance, Carequality, and eHealth Exchange.
Furthermore, significant growth drivers such as increased investments to improve healthcare facilities, and favorable government initiatives to improve patient care are expected to drive the market in the forecast period.
Challenges associated with interoperability solutions
Despite the advancement and adoption of EHR technology, these systems continue to contribute to data silos, making interoperability a significant challenge. For instance, the lack of a national patient identifier is one of the most significant barriers to true EHR interoperability (NPID) where EHRs are the primary repositories and means of access to patient and health data, a major issue is the inability to identify patients and match patient records across and within healthcare provider settings.
Segment Analysis
The global healthcare data interoperability market is segmented based on level, type, end user, and region.
The EHR Interoperability segment accounted for approximately 48.5% of the market share
The EHR Interoperability segment is expected to hold the largest market share over the period forecast. Interoperable electronic health records (EHR) enable the electronic sharing of patient information between different EHR systems and healthcare providers, making it easier for doctors to provide care to their patients and move in and out of different care facilities. EHR is widely regarded as one of the simplest and most secure options that do not result in information blocking.
For instance, in May 2021, Automation Anywhere, Inc. launched its new cloud-based Epic Fast Healthcare Interoperability Resources (FHIR) API Bot to automate access to electronic health records (EHR) for Epic Systems which is one of the largest EHR vendors in the United States.
Additionally, in April 2023, Intermountain Health medical informaticists developed a clinical decision support platform that uses evidence-based medicine and artificial intelligence to accelerate patient treatment and integrate with electronic health records in real-time. Hence, due to the above factors, the segment is expected to hold the largest market share.
Geographical Analysis
North America is expected to hold a significant position in the global healthcare data interoperability market share
North America has maintained a significant market proportion due to factors such as the rising demand for digital healthcare services, product launches, and increasing healthcare expenditure, this trend is anticipated to continue throughout the forecast period.
For instance, in February 2023, Redox, a leader in healthcare interoperability, and Google Cloud partnered to simplify the exchange of healthcare data so organizations can make better and faster decisions.
Additionally, in July 2023, GroundGame.Health (GGH) in partnership with USAing launched the new interoperability and data affinity group at the 2023 conference and tradeshow.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant positive impact on the global healthcare data interoperability market. From comprehending a single patient's entire medical journey to analyzing aggregated data at the community level, frontline providers and researchers require access to the most comprehensive data sets available to track the disease, determine which protocols are most effective, and stay ahead of the virus.
Interoperability has many benefits for measuring vaccine efficacy at the population level. Scientists can study the impact of vaccines on different populations and the implications of distribution inequities in traditionally underserved populations when data can be shared at the macro level.
Market Segmentation
By Level
• Foundational
• Structural
• Semantic
• Organizational
By Type
• Solutions
o EHR Interoperability
o HIE Interoperability
o Others
• Services
By End User
• Healthcare Providers
• Healthcare Payers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Koninklijke Philips N.V., Epic Systems Corporation, Veradigm LLC, Cerner Corporation, Orion Health, OSP Labs, CES Limited, NextGen Healthcare Inc., ViSolve Inc., and InterSystems Corporation among others.
Key Developments
• In October 2023, Philips introduced the interoperability of Philips Capsule Medical Device Information Platform (MDIP) with Philips Patient Information Center iX by providing hospitals with a first of its kind.
Why Purchase the Report?
• To visualize the global healthcare data interoperability market segmentation based on type, capsule size, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of healthcare data interoperability market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global healthcare data interoperability market report would provide approximately 61 tables, 63 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Level
3.2. Snippet by Type
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing adoption of digital healthcare solutions
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Challenges associated with interoperability solutions
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Level
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
7.1.2. Market Attractiveness Index, By Level
7.2. Foundational*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Structural
7.4. Semantic
7.5. Organizational
8. By Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.1.2. Market Attractiveness Index, By Type
8.2. Solutions*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. EHR Interoperability
8.2.4. HIE Interoperability
8.2.5. Others
8.3. Services
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Healthcare Providers*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Healthcare Payers
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Koninklijke Philips N.V.
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Epic Systems Corporation
12.3. Veradigm LLC
12.4. Cerner Corporation
12.5. Orion Health
12.6. OSP Labs
12.7. CES Limited
12.8. NextGen Healthcare Inc.
12.9. ViSolve Inc.
12.10. InterSystems Corporation
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Koninklijke Philips N.V., 4.	Key Developments, Epic Systems Corporation, Veradigm LLC, Cerner Corporation, Orion Health, OSP Labs, CES Limited, NextGen Healthcare Inc., ViSolve Inc., InterSystems Corporation

표 목록 (Tables)

List of Tables

Table 1 Global Healthcare Data Interoperability Market Value, By Level, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Healthcare Data Interoperability Market Value, By Type, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Healthcare Data Interoperability Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Healthcare Data Interoperability Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Healthcare Data Interoperability Market Value, By Level, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Healthcare Data Interoperability Market Value, By Level, 2022-2031 (US$ Million)

Table 7 Global Healthcare Data Interoperability Market Value, By Type, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Healthcare Data Interoperability Market Value, By Type, 2022-2031 (US$ Million)

Table 9 Global Healthcare Data Interoperability Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Healthcare Data Interoperability Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Healthcare Data Interoperability Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Healthcare Data Interoperability Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Healthcare Data Interoperability Market Value, By Level, 2022-2031 (US$ Million)

Table 14 North America Healthcare Data Interoperability Market Value, By Type, 2022-2031 (US$ Million)

Table 15 North America Healthcare Data Interoperability Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Healthcare Data Interoperability Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Healthcare Data Interoperability Market Value, By Level, 2022-2031 (US$ Million)

Table 18 South America Healthcare Data Interoperability Market Value, By Type, 2022-2031 (US$ Million)

Table 19 South America Healthcare Data Interoperability Market Value, By End User, 2022-2031 (US$ Million)

Table 20 South America Healthcare Data Interoperability Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Healthcare Data Interoperability Market Value, By Level, 2022-2031 (US$ Million)

Table 22 Europe Healthcare Data Interoperability Market Value, By Type, 2022-2031 (US$ Million)

Table 23 Europe Healthcare Data Interoperability Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Healthcare Data Interoperability Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Healthcare Data Interoperability Market Value, By Level, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Healthcare Data Interoperability Market Value, By Type, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Healthcare Data Interoperability Market Value, By End User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Healthcare Data Interoperability Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Healthcare Data Interoperability Market Value, By Level, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Healthcare Data Interoperability Market Value, By Type, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Healthcare Data Interoperability Market Value, By End User, 2022-2031 (US$ Million)

Table 32 Koninklijke Philips N.V.: Overview

Table 33 Koninklijke Philips N.V.: Product Portfolio

Table 34 Koninklijke Philips N.V.: Key Developments

Table 35 Epic Systems Corporation: Overview

Table 36 Epic Systems Corporation: Product Portfolio

Table 37 Epic Systems Corporation: Key Developments

Table 38 Veradigm LLC: Overview

Table 39 Veradigm LLC: Product Portfolio

Table 40 Veradigm LLC: Key Developments

Table 41 Cerner Corporation: Overview

Table 42 Cerner Corporation: Product Portfolio

Table 43 Cerner Corporation: Key Developments

Table 44 Orion Health: Overview

Table 45 Orion Health: Product Portfolio

Table 46 Orion Health: Key Developments

Table 47 OSP Labs: Overview

Table 48 OSP Labs: Product Portfolio

Table 49 OSP Labs: Key Developments

Table 50 CES Limited: Overview

Table 51 CES Limited: Product Portfolio

Table 52 CES Limited: Key Developments

Table 53 NextGen Healthcare Inc.: Overview

Table 54 NextGen Healthcare Inc.: Product Portfolio

Table 55 NextGen Healthcare Inc.: Key Developments

Table 56 ViSolve Inc.: Overview

Table 57 ViSolve Inc.: Product Portfolio

Table 58 ViSolve Inc.: Key Developments

Table 59 InterSystems Corporation: Overview

Table 60 InterSystems Corporation: Product Portfolio

Table 61 InterSystems Corporation: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 2 Global Healthcare Data Interoperability Market Share, By Level, 2022 & 2030 (%)

Figure 3 Global Healthcare Data Interoperability Market Share, By Type, 2022 & 2030 (%)

Figure 4 Global Healthcare Data Interoperability Market Share, By End User, 2022 & 2030 (%)

Figure 5 Global Healthcare Data Interoperability Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Healthcare Data Interoperability Market Y-o-Y Growth, By Level, 2022-2030 (%)

Figure 7 Foundational Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 8 Structural Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 9 Semantic Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 10 Organizational Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 11 Global Healthcare Data Interoperability Market Y-o-Y Growth, By Type, 2022-2030 (%)

Figure 12 Solutions Type in Global Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 13 Services Type in Global Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 14 Global Healthcare Data Interoperability Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 15 Heathcare Providers End User in Global Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 16 Healthcare Payers End User in Global Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 17 Others End User in Global Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 18 End User in Global Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 19 Global Healthcare Data Interoperability Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 20 North America Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 21 Asia-Pacific Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 22 Europe Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 23 South America Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 24 Middle East and Africa Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 25 North America Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 26 North America Healthcare Data Interoperability Market Share, By Level, 2022 & 2030 (%)

Figure 27 North America Healthcare Data Interoperability Market Share, By Type, 2022 & 2030 (%)

Figure 28 North America Healthcare Data Interoperability Market Share, By End User, 2022 & 2030 (%)

Figure 29 North America Healthcare Data Interoperability Market Share, By Country, 2022 & 2030 (%)

Figure 30 South America Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 31 South America Healthcare Data Interoperability Market Share, By Level, 2022 & 2030 (%)

Figure 32 South America Healthcare Data Interoperability Market Share, By Type, 2022 & 2030 (%)

Figure 33 South America Healthcare Data Interoperability Market Share, By End User, 2022 & 2030 (%)

Figure 34 South America Healthcare Data Interoperability Market Share, By Country, 2022 & 2030 (%)

Figure 35 Europe Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 36 Europe Healthcare Data Interoperability Market Share, By Level, 2022 & 2030 (%)

Figure 37 Europe Healthcare Data Interoperability Market Share, By Type, 2022 & 2030 (%)

Figure 38 Europe Healthcare Data Interoperability Market Share, By End User, 2022 & 2030 (%)

Figure 39 Europe Healthcare Data Interoperability Market Share, By Country, 2022 & 2030 (%)

Figure 40 Asia-Pacific Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 41 Asia-Pacific Healthcare Data Interoperability Market Share, By Level, 2022 & 2030 (%)

Figure 42 Asia-Pacific Healthcare Data Interoperability Market Share, By Type, 2022 & 2030 (%)

Figure 43 Asia-Pacific Healthcare Data Interoperability Market Share, By End User, 2022 & 2030 (%)

Figure 44 Asia-Pacific Healthcare Data Interoperability Market Share, By Country, 2022 & 2030 (%)

Figure 45 Middle East & Africa Healthcare Data Interoperability Market Value, 2022-2031 (US$ Million)

Figure 46 Middle East & Africa Healthcare Data Interoperability Market Share, By Level, 2022 & 2030 (%)

Figure 47 Middle East & Africa Healthcare Data Interoperability Market Share, By Type, 2022 & 2030 (%)

Figure 48 Middle East & Africa Healthcare Data Interoperability Market Share, By End User, 2022 & 2030 (%)

Figure 49 Koninklijke Philips N.V.: Financials

Figure 50 Epic Systems Corporation: Financials

Figure 51 Veradigm LLC: Financials

Figure 52 Cerner Corporation: Financials

Figure 53 Orion Health: Financials

Figure 54 OSP Labs: Financials

Figure 55 CES Limited: Financials

Figure 56 NextGen Healthcare Inc.: Financials

Figure 57 ViSolve Inc.: Financials

Figure 58 InterSystems Corporation: Financials

글로벌 의료 데이터 상호운용성 시장 – 2023-2030

Global Healthcare Data Interoperability Market - 2023-2030